Advertisement
Advanced Search

To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.

Figures

Fig

Patient screening and exclusion by criteria.

Abstract

Background

Clopidogrel is an adenosine diphosphate receptor antagonist. The risk of intracranial hemorrhage following minor head trauma in patients with pre-injury use of clopidogrel has not been fully determined.

Methods

This case-controlled study examined the effects of pre-injury use of clopidogrel in adult (age 14 years and older) patients with minor head trauma.

Results

During the study period, 1660 patients head computed tomography scans were performed in the emergency department, of which 658 met inclusion criteria. Intracranial hemorrhage was noted in 30% of patients on clopidogrel, compared with 2.2% of those patients without pre-injury use of clopidogrel. After performing a logistic regression analysis for confounders, the pre-injury use of clopidogrel was significantly associated with intracranial hemorrhage in this study population (OR 16.7; 95% CI 1.71-162.7).

Conclusion

The use of clopidogrel is associated with a significantly increased risk of developing intracranial hemorrhage following minor trauma.

To access this article, please choose from the options below

Log In


Forgot password?

Register

Create a new account

Purchase access to this article

Claim Access

If you are a current subscriber with Society Membership or an Account Number, claim your access now.

Subscribe to this title

Purchase a subscription to gain access to this and all other articles in this journal.

Institutional Access

Visit ScienceDirect to see if you have access via your institution.

There are no financial, litigational, or other conflicts of interest to disclose.

☆☆The data have been previously published as an abstract at the Society of Emergency Medicine's Annual Meeting, 2013.

Author contribution statement: All authors provided meaningful contributions to the manuscript, and meet criteria for authorship. Michael Levine takes responsibility for the manuscript in its entirety. There are no financial, litigational, or other conflicts of interest to disclose.

Related Articles

Searching for related articles..

Advertisement